FABP2 and serum lipopolysaccharide activity: As expected, significantly decreased plasma LPS and I-FABP levels were observed in mice with DHM administration, compared to the HIE-treated mice, implying a reduced endotoxemia resulted from the DHM supplement (Figure 2A,B).